Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials
By P. Kearney, C. Baigent, J. Godwin, H. Halls, J. Emberson, C. Patrono. British medical journal, 2006
1,442 citations recorded by the source corpus.
Subfields: Biochemistry, Cardiology and Cardiovascular Medicine, Pharmacology
View Paper: https://www.semanticscholar.org/paper/d8aaf815279ac16ea378671baced4c22b9ac7b8c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Pharmacology
Citations in the corpus
- 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2008, background): “The risk appears to be amplified in patients with established cardiovascular disease (15,18, 19 ).”
- Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications. (2014, neutral): “(179) have reviewed the clinical trials for vascular events resulted from the use of NSAIDs.”
- Pharmacological management of persistent pain in older persons. (2009, background): “Of the traditional NSAIDs, diclofenac has been identified as possessing potentially higher risk for adverse cardiovascular events.(88,89) Although earlier recommendations suggested a trial of NSAIDs if acetaminophen is ineffective, newer information suggests that this is often a risky strategy in ol”
- 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014, background): “In all cases, use of the lowest effective doses for the shortest possible time is encouraged (117,118,252,253).”
- 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2008, background): “The risk appears to be amplified in patients with established cardiovascular disease.(15,18,19) Gislason et al.”
- Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis (2011, background): “Small studies would have had minimal impact on the analysis anyway, because of low numbers of events.”